Tag: kamp

DeLauro's House Bill to Restrict DTC Advertising Likely Would Violate First Amendment

CDER’s Woodcock Says FDA Is Meeting GDUFA Challenges at House Pricing Hearing

Industry More Than Ready for FDA Off-label Communications Guidance

Are DTC Ads Being Mischaracterized?

Pacira Prevails in Exparel Settlement with FDA

AMA Calls for DTC Advertising Ban

PhRMA Puts Drug Costs in Perspective as Pricing Scrutiny Increases

Kaiser Poll: DTC Ads Have High Profile, But Mixed Reviews

Prescription Drug Marketing Targeted by Hillary Clinton